BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11463928)

  • 1. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Jager HC; Coutinho RA
    Value Health; 2001; 4(3):266-75. PubMed ID: 11705188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?
    Ong KJ; Soldan K; Jit M; Dunbar JK; Woodhall SC
    Sex Transm Infect; 2017 Feb; 93(1):18-24. PubMed ID: 27288417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.
    Rours GI; Smith-Norowitz TA; Ditkowsky J; Hammerschlag MR; Verkooyen RP; de Groot R; Verbrugh HA; Postma MJ
    Pathog Glob Health; 2016; 110(7-8):292-302. PubMed ID: 27958189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
    Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
    Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.
    Howell MR; Quinn TC; Brathwaite W; Gaydos CA
    Sex Transm Dis; 1998 Feb; 25(2):108-17. PubMed ID: 9518379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis.
    Washington AE; Browner WS; Korenbrot CC
    JAMA; 1987 Apr; 257(15):2056-60. PubMed ID: 3104627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis.
    Price MJ; Ades AE; Soldan K; Welton NJ; Macleod J; Simms I; DeAngelis D; Turner KM; Horner PJ
    Health Technol Assess; 2016 Mar; 20(22):1-250. PubMed ID: 27007215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are oral contraceptives masking symptoms of chlamydial cervicitis and pelvic inflammatory disease?
    Mårdh PA; Hogg B
    Eur J Contracept Reprod Health Care; 1998 Mar; 3(1):41-3. PubMed ID: 9678072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project.
    Roberts TE; Robinson S; Barton PM; Bryan S; McCarthy A; Macleod J; Egger M; Low N
    BMJ; 2007 Aug; 335(7614):291. PubMed ID: 17656504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.
    Nyári T; Nyári C; Woodward M; Mészáros G; Deák J; Nagy E; Kovács L
    Acta Obstet Gynecol Scand; 2001 Apr; 80(4):300-6. PubMed ID: 11264602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach.
    Welte R; Kretzschmar M; Leidl R; van den Hoek A; Jager JC; Postma MJ
    Sex Transm Dis; 2000 Oct; 27(9):518-29. PubMed ID: 11034526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.
    van Bergen JE; Postma MJ; Peerbooms PG; Spangenberg AC; Tjen-A-Tak J; Bindels PJ
    Int J STD AIDS; 2004 Dec; 15(12):797-802. PubMed ID: 15601485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.